IDSI wins contract with Canadian firm

Article

Breast imaging device developer Imaging Diagnostic Systems has received an order for its CT Laser Mammography system (CTLM), a work-in-progress device that uses infrared laser light to image breast tissue. The company signed an agreement at the RSNA show

Breast imaging device developer Imaging Diagnostic Systems has received an order for its CT Laser Mammography system (CTLM), a work-in-progress device that uses infrared laser light to image breast tissue. The company signed an agreement at the RSNA show last month with Cycle of Life Technologies of Toronto for two of the units. The deal should bring in approximately $500,000, the first revenues generated by the Fort Lauderdale, FL, firm since it was established. IDSI expects to deliver the devices during the first quarter of next year.

The agreement also covers the delivery of two more CTLM devices once the first order has been fulfilled, as well as a distribution contract for 50 systems over the next two years. Cycle of Life Technologies supplies medical services and equipment to clients in Canada, Europe, South Africa, and the Middle East.

Since IDSI has yet to apply for premarket approval from the Food and Drug Administration for CTLM, the company must obtain an export certificate from the agency before it can ship the system. The certificate application must include letters from each country Cycle of Life Technologies services stating that the country will accept a non-FDA-approved device for import.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.